These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. Human T cell clones, tolerance, and the analysis of autoimmunity. Feldmann M; Lamb JR; Londei M Curr Top Microbiol Immunol; 1986; 126():207-11. PubMed ID: 3487425 [No Abstract] [Full Text] [Related]
35. [Discovery and study of a serum hemagglutination-inhibiting factor in Basedow's disease]. Wilkin TJ; Beck JS; Hayes PD; Potts R Ann Endocrinol (Paris); 1979; 40(1):57-8. PubMed ID: 582091 [No Abstract] [Full Text] [Related]
36. Abnormal thyrotropic substance in the pituitaries of patients with Graves' disease. Kumahara Y; Iwatsubo H; Miyai K; Masui H; Fukuchi M; Abe H J Clin Endocrinol Metab; 1967 Mar; 27(3):333-40. PubMed ID: 6071552 [No Abstract] [Full Text] [Related]
37. [Serotonin metabolism in patients with disturbed thyroid gland function]. Golovach AP Probl Endokrinol (Mosk); 1968; 14(3):97-100. PubMed ID: 5757100 [No Abstract] [Full Text] [Related]
38. Small intestinal functions in Graves' disease with special reference to thyroid antibodies. Rao PS; Gupta PS; Rao B; Ghosh BK; Prakash P; Misra RC Indian J Med Res; 1981 Jan; 73():96-100. PubMed ID: 6894585 [No Abstract] [Full Text] [Related]
39. [Antibodies against the TSH receptor (TSAb) in Graves' disease and other thyroid diseases]. Gómez Sáez JM; Navarro Moreno MA; Soler Ramón J; Bonnin Lafuente R Med Clin (Barc); 1982 Dec 1-31; 79(10):437-40. PubMed ID: 6130193 [No Abstract] [Full Text] [Related]
40. No prognostic value of thyroid autoantibodies changes during and after methimazole therapy in patients with Graves' disease. Lattanzi V; Ciampolillo A; Vincenti C; Giorgino R Boll Soc Ital Biol Sper; 1985 Apr; 61(4):507-13. PubMed ID: 3840026 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]